An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women
暂无分享,去创建一个
O. Johnell | L. Palermo | D. Black | R. Lindsay | R. Lindsay | M. Steinbuch | P. Dargent-Molina | O. Johnell | D. M. Black | M. Steinbuch | L. Palermo | P. Dargent-Molina | R. Lindsay | M. S. Hoseyni | M. Hoseyni | D. Black
[1] H K Genant,et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. , 1999, JAMA.
[2] S. Cummings,et al. Bone density at various sites for prediction of hip fractures , 1993, The Lancet.
[3] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[4] W C Hayes,et al. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. , 1994, JAMA.
[5] J Pearson,et al. Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] T. Abbott,et al. Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] G. Breart,et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study , 1996, The Lancet.
[8] S. Cummings,et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.
[9] A. Hofman,et al. Added value of bone mineral density in hip fracture risk scores. , 1999, Bone.
[10] R. Stine,et al. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. , 1998, The American journal of managed care.
[11] L. Melton,et al. The worldwide problem of osteoporosis: insights afforded by epidemiology. , 1995, Bone.
[12] S. Cummings,et al. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. , 1989, Archives of internal medicine.
[13] D. Hans,et al. How Hip and Whole-Body Bone Mineral Density Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study , 1998, Osteoporosis International.
[14] Harry K. Genant,et al. Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-year Randomized Clinical Trial , 2000 .
[15] C. Baudoin,et al. Separate and Combined Value of Bone Mass and Gait Speed Measurements in Screening for Hip Fracture Risk: Results from the EPIDOS Study , 1999, Osteoporosis International.
[16] O. Johnell,et al. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures , 1996 .
[17] C. Cooper,et al. Epidemiology of osteoporosis. , 2001, Rheumatic diseases clinics of North America.
[18] A. Hofman,et al. Hip Fracture Prediction in Elderly Men and Women: Validation in the Rotterdam Study , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] H K Genant,et al. Defining Incident Vertebral Deformity: A Prospective Comparison of Several Approaches , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] A. LaCroix,et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. , 1998, JAMA.